Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thromboembolism × Tinzaparin × Clear all

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

palbociclib 1 Tinzaparin 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Dalteparin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05178628 2022-03-29

imPaCT-PRO

Institute of Molecular Medicine and Biomedical Research

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡